Literature DB >> 16475731

Heparin increases human gastric carcinoma cell growth.

William Ka Kei Wu1, Vivian Yvonne Shin, Yi Ni Ye, Helen Pui Shan Wong, Fung Yu Huang, Marco King Cheung Hui, Emily Kai Yee Lam, Chi Hin Cho.   

Abstract

BACKGROUND: Heparin has been widely used to prevent cancer-associated thromboembolism in cancer patients. Recent evidence reveals that heparin could modulate cell proliferation in the stomach. The effect of heparin on gastric cancer growth, however, is unknown. The effect of heparin on the proliferation of a human gastric adenocarcinoma cell line, BGC-823, was investigated.
MATERIALS AND METHODS: Cell proliferation was assessed by [3H]-thymidine incorporation. The expressions of several growth-related genes were determined by RT-PCR and Western blot.
RESULTS: Heparin significantly increased cell proliferation in BGC-823 cancer cells by 15.5% at the dose of 0.2 microg/ml. Heparin also up-regulated c-Myc protein expression by 14.4%. In contrast, mRNA and protein levels of epidermal growth factor receptor (EGFR) were, respectively, down-regulated by 12.7% and 8.2% with no effect on cyclooxygenase-2 mRNA or protein expression.
CONCLUSION: Our results suggest that heparin can promote the proliferation and up-regulation of c-Myc protein expression in gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475731

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

2.  Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate.

Authors:  Sandra Laner-Plamberger; Thomas Lener; Doris Schmid; Doris A Streif; Tina Salzer; Michaela Öller; Cornelia Hauser-Kronberger; Thorsten Fischer; Volker R Jacobs; Katharina Schallmoser; Mario Gimona; Eva Rohde
Journal:  J Transl Med       Date:  2015-11-10       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.